U.S. regulators Wednesday approved the first drug for the treatment of Ebola. The Food and Drug Administration OK’d the drug developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola virus strain, the most deadly of six known types. It typically kills 60% to 90% of patients. The drug was one of […]
Home »
RUNX proteins act as regulators in DNA repair, study finds
A study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has revealed that RUNX proteins are integral to efficient DNA repair via the Fanconi Anemia (FA) pathway. Led by Professor Yoshiaki Ito, Senior Principal Investigator at CSI Singapore, and involving Senior Research Scientist Dr. Vaidehi Krishnan […]